Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Mytos
Mytos automates large-scale production of human cells to make regenerative medicines and drug-discovery assays more scalable and consistent. The company uses its iDEM™ robotics platform and automated…
Mytos
Mytos automates large-scale production of human cells to make regenerative medicines and drug-discovery assays more scalable and consistent. The company uses its iDEM™ robotics platform and automated…
TL;DR
What they do: Automated cell-manufacturing platform (iDEM™) and automated CDMO for regenerative medicine and drug-discovery assays
Founded: 2016
Founders / leadership: Co‑founders: Ali Afshar (CEO) and Ignacio Willats
Funding signal: Reportedly raised >$24M; public references to a $19M Series A
Headcount (reported): 47 employees
Company Overview
Problem Domain
Regenerative medicine and drug-discovery/testing where manual cell-culture processes limit scalability, consistency, and cost-effectiveness.
Founded
2016
Industry
Biotechnology Research
Tech Stack
Funding Track Record
$19,000,000
Public reporting and company newsroom reference a $19M Series A
Investor Signal
“Syndicate includes venture investors and angel/backer individuals (examples named in company materials and databases include Acequia Capital, Cur8 Capital, Buckley Ventures and others)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,400+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |